EANO guidelines for the diagnosis and treatment of ependymal tumors
Top Cited Papers
Open Access
- 29 November 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 20 (4), 445-456
- https://doi.org/10.1093/neuonc/nox166
Abstract
Ependymal tumors are rare CNS tumors and may occur at any age, but their proportion among primary brain tumors is highest in children and young adults. Thus, the level of evidence of diagnostic and therapeutic interventions is higher in the pediatric compared with the adult patient population. The diagnosis and disease staging is performed by craniospinal MRI. Tumor classification is achieved by histological and molecular diagnostic assessment of tissue specimens according to the World Health Organization (WHO) classification 2016. Surgery is the crucial initial treatment in both children and adults. In pediatric patients with intracranial ependymomas of WHO grades II or III, surgery is followed by local radiotherapy regardless of residual tumor volume. In adults, radiotherapy is employed in patients with anaplastic ependymoma WHO grade III, and in case of incomplete resection of WHO grade II ependymoma. Chemotherapy alone is reserved for young children <12 months and for adults with recurrent disease when further surgery and irradiation are no longer feasible. A gross total resection is the mainstay of treatment in spinal ependymomas, and radiotherapy is reserved for incompletely resected tumors. Nine subgroups of ependymal tumors across different anatomical compartments (supratentorial, posterior fossa, spinal) and patient ages have been identified with distinct genetic and epigenetic alterations, and with distinct outcomes. These findings may lead to more precise diagnostic and prognostic assessments, molecular subgroup-adapted therapies, and eventually new recommendations pending validation in prospective studies.Keywords
This publication has 121 references indexed in Scilit:
- Long-term quality of life in children treated for posterior fossa brain tumorsJournal of Neurosurgery: Pediatrics, 2013
- Outcome of infants and young children with newly diagnosed ependymoma treated on the “Head Start” III prospective clinical trialJournal of Neuro-Oncology, 2013
- Phase II study of pre‐irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2012
- Survival Benefit for Pediatric Patients With Recurrent Ependymoma Treated With ReirradiationInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Copy Number Gain of 1q25 Predicts Poor Progression-Free Survival for Pediatric Intracranial Ependymomas and Enables Patient Risk Stratification: A Prospective European Clinical Trial Cohort Analysis on Behalf of the Children's Cancer Leukaemia Group (CCLG), Société Française d'Oncologie Pédiatrique (SFOP), and International Society for Pediatric Oncology (SIOP)Clinical Cancer Research, 2012
- Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohortsJournal of Negative Results in BioMedicine, 2011
- Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium StudyJournal of Clinical Oncology, 2010
- Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patientsNeuro-Oncology, 2010
- Adult ependymal tumors: prognosis and the M. D. Anderson Cancer Center experienceNeuro-Oncology, 2010
- Intracranial Ependymomas in Children: Society of Pediatric Oncology Experience With Postoperative Hyperfractionated Local RadiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2009